Skip to Content
Print Save

G 0511 G 0511 (Fenofibrate (Micronized) 67 mg)

Pill with imprint G 0511 G 0511 is Yellow, Capsule-shape and has been identified as Fenofibrate (Micronized) 67 mg. It is supplied by Global Pharmaceuticals.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 67 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 0511 G 0511

Fenofibrate (micronized) 67 mg G 0511 G 0511
Fenofibrate (micronized) 67 mg G 0511 G 0511
Fenofibrate (micronized) 67 mg G 0511 G 0511 Front
Fenofibrate (micronized) 67 mg G 0511 G 0511 Back
Fenofibrate (micronized) 67 mg G 0511 G 0511

Fenofibrate (Micronized)

Imprint
G 0511 G 0511
Strength
67 mg
Color
Yellow
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Global Pharmaceuticals
National Drug Code (NDC)
00115-0511
Inactive Ingredients
croscarmellose sodium, hypromellose 2910 (6 mPa.s), magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, gelatin, titanium dioxide, D&C Yellow No. 10, FD&C Yellow No. 6, shellac, ferrosoferric oxide, propylene glycol, FD&C Blue No. 2, FD&C Red No. 40, aluminum oxide, FD&C Blue No. 1

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer